In 1974, Merck Millipore was the first to market a closed filtration device: Steritest?. Since this time, through dedicated research & development, we have been instrumental in raising the industry?s ...

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Germany, says it has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra™ CHO genetic ...

Merck Millipore has launched a Campylobacter detection kit for poultry to test for the bacteria on the farm immediately prior to slaughter. The Singlepath Direct Campy Poultry Kit for onsite ...

Merck Millipore has said environmental monitoring in the food and beverage industry is a current key focus, especially in North America. Environmental monitoring avoids risks to consumers and ...

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, has opened its new $286 million biosafety testing facility in Rockville. Biosafety testing and analytical ...

Rockville, MD—MilliporeSigma rolled out the proverbial red carpet, state and local dignitaries, Maryland crab cakes, and a giant scissors with which to cut a company-branded yellow ribbon as it ...

This will help increase the company's ability to conduct biosafety testing and analytical development services. BURLINGTON — MilliporeSigma’s Life Science business sector is investing more than $286 ...

Partnership builds on more than a decade of collaboration, reinforcing MilliporeSigma’s role in supporting the safe, reliable commercialization of novel modalities MilliporeSigma, the U.S. and Canada ...

Facility consolidates biosafety testing, analytical development, and cell bank manufacturing services into single building New rapid test offering with Blazar ® CHO Animal Origin Free (AOF) delivers ...

Merck’s life science business has been awarded a three-year, $136.7 million contract to stand up a factory for a critical material needed to manufacture rapid COVID-19 point-of-care tests.

MilliporeSigma enters five-year agreement to provide end-to-end testing services for Genetix Biotherapeutics’ commercial therapies Partnership builds on more than a decade of collaboration, ...